Why our preservative does not promote pathogenic resistance?
Vetricept is a topical solution containing a patented formulation that provides a consistent in-vitro antimicrobial effect to keep the solution safe during multiple uses (per product labeling). Vetricept Hydrogel also reduces topical itch and pain, and creates a safe moist environment to allow wounds to heal.
HOCl and The Body
HOCl is produced by your pet's immune system during a process called phagocytosis which is used to eliminate viruses, bacteria, and other pathogens. Phagocytes destroy pathogens in a process whereby myeloperoxidase, in a delicate combination with hydrogen peroxide creates HOCl. Similar to our own bodies, animal immune systems produce HOCl when fighting infections. Vetricept uses HOCl to provide a safe solution for moistening and debriding wounds to allow the body to heal.
A Natural Solution
HOCl does not rely on a single mode of action to block or eradicate viruses, fungi, bacteria, or spores; it does not produce resistance amongst pathogens. Studies demonstrate that HOCl does not promote the emergence of microbial resistance. At the same time, it remains highly effective in the eradication of antibiotic-resistant bacteria or “superbugs”. This multi-prong mechanism of HOCl involvement leads to the rapid deactivation of viruses and the destruction of pathogens (bacteria, viruses and fungi) in solution thus, helping to maintain the integrity of the solution during multiple uses for up to 28 days after opening.
In-vitro Antimicrobial
HOCl damages bacteria by infiltrating the integrity of bacterial cell membranes by increasing its permeability (the ability to allow or pass through). HOCl helps disrupt the energy cycle in bacteria (ATP), which is the central powerhouse for the production of energy and a universal, biological energy storage and transfer molecule. This distruption short circuits the bacterial cells power supply lines. This two-punch combo of cell membrane damage & halting of ATP production helps eradicate the pathogen.
In-vitro Antiviral
HOCl destroys viruses by breaking their structure. Once the viral structure of a virus is compromised, it can no longer cause an infection. This multi-prong mechanism of HOCl involvement leads to the rapid deactivation of viruses.
In-vitro Antifungal
HOCl targets and blocks kinase molecules (the signaling and circuitry “wires” of cells). This “interference” triggers a cascade of events leading to the complete cell destruction in fungi.